Skip to main content
45°
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich Pendulum
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
Classifieds
Place ad
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Bicycle Therapeutics Plc ADR
(NQ:
BCYC
)
22.68
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
22.68
Bid (Size)
9.120 (1)
Ask (Size)
26.50 (1)
Prev. Close
22.68
Today's Range
22.68 - 22.68
52wk Range
12.54 - 28.91
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Expert Ratings For Bicycle Therapeutics
April 10, 2024
Via
Benzinga
Bicycle Therapeutics to Participate in the 23rd Annual Needham Virtual Healthcare Conference
April 02, 2024
From
Bicycle Therapeutics plc
Via
Business Wire
Performance
YTD
+22.99%
+22.99%
1 Month
-10.81%
-10.81%
3 Month
+27.99%
+27.99%
6 Month
+42.64%
+42.64%
1 Year
+12.33%
+12.33%
More News
Read More
Bicycle Therapeutics to Present at the AACR Annual Meeting 2024
March 05, 2024
From
Bicycle Therapeutics plc
Via
Business Wire
Bicycle Therapeutics to Participate in Upcoming Investor Conferences
February 28, 2024
From
Bicycle Therapeutics plc
Via
Business Wire
The Analyst Landscape: 4 Takes On Bicycle Therapeutics
February 21, 2024
Via
Benzinga
Forecasting The Future: 4 Analyst Projections For Bicycle Therapeutics
December 20, 2023
Via
Benzinga
Expert Ratings for Bicycle Therapeutics
November 03, 2023
Via
Benzinga
Walmart To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Wednesday
February 21, 2024
Via
Benzinga
Bicycle Therapeutics Reports Recent Business Progress and Fourth Quarter and Full Year 2023 Financial Results
February 20, 2024
From
Bicycle Therapeutics plc
Via
Business Wire
12 Health Care Stocks Moving In Tuesday's Intraday Session
February 13, 2024
Via
Benzinga
Bicycle Therapeutics to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference
February 07, 2024
From
Bicycle Therapeutics plc
Via
Business Wire
Where Bicycle Therapeutics Stands With Analysts
September 07, 2023
Via
Benzinga
Expert Ratings for Bicycle Therapeutics
August 04, 2023
Via
Benzinga
Constellation Energy, Battalion Oil And Other Big Stocks Moving Higher On Friday
December 15, 2023
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Bicycle Therapeutics Provides Data Updates for Three Clinical Programs and Strategy Overview at First R&D Day
December 14, 2023
From
Bicycle Therapeutics
Via
Business Wire
La-Z-Boy Posts Upbeat Earnings, Joins Victoria's Secret, Snowflake And Other Big Stocks Moving Higher On Thursday
November 30, 2023
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Bicycle Therapeutics to Host R&D Day on December 14
November 30, 2023
From
Bicycle Therapeutics
Via
Business Wire
9 Health Care Stocks With Whale Alerts In Today's Session
November 16, 2023
Via
Benzinga
Bicycle Therapeutics Reports Recent Business Progress and Third Quarter 2023 Financial Results and Announces Upcoming R&D Day
November 02, 2023
From
Bicycle Therapeutics plc
Via
Business Wire
Bicycle Therapeutics to Participate in Upcoming Investor Conferences
October 30, 2023
From
Bicycle Therapeutics plc
Via
Business Wire
Bicycle Therapeutics Selected to Participate in FDA Program to Expedite Commercial Manufacturing Readiness of BT8009 for Metastatic Bladder Cancer
October 19, 2023
From
Bicycle Therapeutics
Via
Business Wire
Why Shares of Bicycle Therapeutics Were Rising on Monday
September 11, 2023
Via
The Motley Fool
Exposures
Product Safety
Bicycle Therapeutics Announces Expedited Development Plan for BT8009 in Metastatic Bladder Cancer
September 11, 2023
From
Bicycle Therapeutics
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For September 12, 2023
September 12, 2023
Via
Benzinga
Bicycle Therapeutics to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference
September 05, 2023
From
Bicycle Therapeutics
Via
Business Wire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.